Article
Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology
21 Apr 2022
Abstract excerpt
Molecular tests are necessary to stratify cancer patients for targeted therapy. However, high cost and technical barriers limit the application of these tests, hindering optimal treatment. Recently, deep learning (DL) has been applied to predict molecular test results from digitized images of tissue slides. Furthermore, treatment response and prognosis can be predicted from tissue slides using DL. In this review,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
